V9Y-73770-83030
4 vaccinations
6 coded responses
38 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 104 / NY
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-18
Registered in v-safe
-
2021-02-18
Dose 1 — Pfizer-BioNTech
- 2021-02-18
-
2021-02-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, DiarrheaAdult check-in
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-27
- 2021-03-04
-
2021-03-11
Dose 2 — Pfizer-BioNTech
- 2021-03-11
-
2021-03-12
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Pain in under arm/armpit lymphnodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Good · Site: Pain, Redness · Fatigue or tirednessFree text: Pain in armpit areaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Survey response — days 1–6 daily, dose 2MedDRA: Poor feeding infant — Feeling: Good · Fatigue or tirednessFree text: Possible side effects in toddler daughter who is breastfeeding. Otherwise none.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-27
- 2021-04-02
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-06-10
-
2021-09-03
Dose 3 — Pfizer-BioNTech
- 2021-09-09
- 2021-10-02
- 2021-10-08
- 2021-10-15
- 2021-12-03
- 2022-03-04
-
2022-09-03
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-07
Survey response — day 7, dose 4MedDRA: Nasopharyngitis, Oropharyngeal pain — Feeling: Fair · Headache, Fatigue or tirednessFree text: Sore throat: probably a cold and unrelatedMedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-12
- 2022-12-30
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Pfizer-BioNTech | |
| 2 | 2021-03-11 | Pfizer-BioNTech | |
| 3 | 2021-09-03 | Pfizer-BioNTech | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | Flu |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): No
Systemic reaction (other): Pain in under arm/armpit lymphnodes
Systemic reaction (other): Pain in armpit area
Systemic reaction (other): Possible side effects in toddler daughter who is breastfeeding. Otherwise none.
Release 12 — 12 months, dose 3
Symptoms: Covid
Release 12 — day 7, dose 4
Systemic reaction (other): Sore throat: probably a cold and unrelated
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Poor feeding infant | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release